Austwick Michael 4
4 · Verona Pharma plc · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Austwick Michael
Director
Transactions
- Award
Share Options (Right to Buy)
2024-02-01+144,000→ 144,000 totalExercise: $2.29Exp: 2034-01-31→ Ordinary Shares (144,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The option vests and becomes exercisable as to one-third of the underlying options on February 1, 2025 and the remainder in eight equal quarterly installments thereafter.